On imaging or histology, how might lymphoma be differentiated from inflammatory bowel disease?

Enhance your understanding of chronic enteropathy with this essential practice test. Utilize multiple choice questions and informative explanations to ensure you’re thoroughly prepared for the exam!

Multiple Choice

On imaging or histology, how might lymphoma be differentiated from inflammatory bowel disease?

Explanation:
A key distinction is that lymphoma tends to form a mass that causes focal or nodular thickening, sometimes with a clear mass effect on imaging, and is confirmed histologically by sheets or clusters of neoplastic lymphocytes invading the mucosa and submucosa. This combination—a discrete mass on imaging and malignant lymphoid cells on biopsy—points to lymphoma rather than inflammatory bowel disease. Inflammatory bowel disease usually shows diffuse or segmental mural thickening due to edema and inflammatory infiltrates, with chronic changes to the mucosa such as crypt distortion or granulomas in Crohn’s, but it does not typically produce a discrete mass of neoplastic lymphocytes. Therefore, the presence of a mass-forming lesion with neoplastic cells is the hallmark differentiator, rather than a mass effect being a feature of inflammatory disease.

A key distinction is that lymphoma tends to form a mass that causes focal or nodular thickening, sometimes with a clear mass effect on imaging, and is confirmed histologically by sheets or clusters of neoplastic lymphocytes invading the mucosa and submucosa. This combination—a discrete mass on imaging and malignant lymphoid cells on biopsy—points to lymphoma rather than inflammatory bowel disease.

Inflammatory bowel disease usually shows diffuse or segmental mural thickening due to edema and inflammatory infiltrates, with chronic changes to the mucosa such as crypt distortion or granulomas in Crohn’s, but it does not typically produce a discrete mass of neoplastic lymphocytes. Therefore, the presence of a mass-forming lesion with neoplastic cells is the hallmark differentiator, rather than a mass effect being a feature of inflammatory disease.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy